Default company panoramic image
Logo

Sanuthera, Inc

Sanuthera is a medical device company with proprietary sound technology for the most effective treatment of tinnitus ("ringing in the ears")

  • Stage Concept Only
  • Industry Medical Devices and Equipment
  • Location Athens, OH, USA
  • Currency USD
  • Website sanuthera.com

Company Summary

Sanuthera alleviates patient suffering for 11M+ sufferers of severe tinnitus, and provides audiologists with a reliable, cost-and-time-efficient tool for diagnosis and customized therapeutics. The Sanuthera device delivers state-of-the-art sound therapy to alleviate symptoms via a medical devices that attache to hearing aids. 86% of tinnitus patients have hearing loss. Sanuthera partners with hearing aid companies for sales and distribution.

Team

  • Default avatar
    Mark Hendrickson
    Interim CFO

    C-level roles in multiple start-ups. Background in financial services, corporate acquisitions, technology programs, and startup management. Previous roles at Thrivent Financial and Royal Bank of Canada. Established relationships with Veterans Administration and manufacturing partners.

  • Default avatar
    Jeffrey DiGiovanni
    Co-Founder and President

    An innovative hearing research scientist and device developer with start-up experience with various medical device enterprises, including St. Croix Medical (now Envoy Medical). Currently serves as the College Clinical Officer for the College of Health Sciences and Professions and an Associate Professor of Audiology in Communication Sciences and Disorders at Ohio University. BA in engineering. MA in clinical audiology, PhD in psychoacoustics..

  • Default avatar
    Stephen Rizzo
    Co-Founder and Vice President

    Retired Chief of Audiology, Department of Veteran Affairs.

  • Default avatar
    Jane New
    Board Member

    Executive in Residence at TechGROWTH Ohio, with deep experience in intellectual property, venture development, equity investment across industry sectors, especially in life sciences. Serves 3 early-stage funds preparing investable deal flow, conducting diligence, and corporate governance.

  • Default avatar
    Richard Giancola
    Board Member

    Distinguished career in hearing device companies both domestic and international, including former CEO of Neuromonics (a Sanuthera competitor and potential acquirer).

  • Default avatar
    Robert Dickey IV
    Board Member

    Currently CEO at NeoStem, Inc., a public cell therapy company. Previous C-level roles in life science companies, investment banking, and entrepreneurial management. Raised over $94M from private capital and over $60M in public markets on behalf of client companies.